HIGHLIGHTS
SUMMARY
2022, 11, 6717. https://doi.org/10.3390/jcm11226717 2 of 22 the most recently published Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) guidelines on the use of biological and small_molecules for ulcerative colitis (UC) make conditional recommendations on the use of some agents over others in naïve patient, but they do not provide a comprehensive therapeutic algorithm. The authors report the main findings coming from the two most recently published NMAs on the comparathetive main findings coming from the two most recently published NMAs on the comparative efficacy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.